Open AccessPD ‐1/ PD‐L1 co‐location: A novel biomarker for immunotherapy response in non‐small cell lung cancer
Author(s) -
Diao Xiayao,
Guo Chao,
Li Shanqing
Publication year - 2022
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.14436
Subject(s) - medicine , pembrolizumab , lung cancer , immunotherapy , immunohistochemistry , pd l1 , biomarker , oncology , cancer , cancer immunotherapy , companion diagnostic , cancer research , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom